Drawing for GX ADHERALINK

USPTO serial 79456083

GX ADHERALINK

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
FLETCHER, TRACY L
Law office
TMO LAW OFFICE 115

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with GX ADHERALINK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Computer software; downloadable and non-downloadable software used to measure, store, collect, transmit, monitor and analyze data from drug delivery devices; software enabling automated and interactive messaging, including chatbot-based communication via third-party messaging platforms; software for integration with messaging services to enable natural language communication with patients without requiring application downloads; software for monitoring patient compliance, medication adherence, and device performance in connection with drug delivery devices; data processing programs; artificial intelligence software for healthcare; computer software for use as an application programming interface (API); wireless transmitters and receivers used with the foregoing; sensors.ACTIVE—
010Medical apparatus and instruments; Medical devices; medical devices for storage, preparation and/or administration of a medical substance; drug delivery devices, in particular auto-injectors, pen injectors, syringes, vials, containers; medical devices incorporating software and sensors for monitoring drug delivery, in particular smart add-on monitoring modules for drug delivery devices, smart closure systems and smart caps; medical devices featuring artificial intelligence; electronic and/or internet-enabled medical devices for transmitting drug delivery data to servers, cloud-based systems and/or electronic end devices.ACTIVE—
042Scientific and technological services; Computer software design and development; design and development of computer software for use in healthcare, medical device monitoring and patient support; design, development, maintenance, and updating of software for patient monitoring and medical device integration; hosting and cloud computing; hosting of databases and server infrastructures for patient-related drug intake data; software as a service (SaaS), platform as a service (PaaS); providing temporary use of non-downloadable software for managing medical device data and patient communications; software as a service (SaaS) for collecting, transmitting, storing, evaluating and monitoring data on medication intake; software as a service (SaaS) for the technical analysis of therapy-related user data; platform as a service (PaaS) for integrating smart medical devices with digital patient communication systems; technical data analysis; automated analysis of user and sensor data; artificial intelligence driven data analysis; provision of application programming interfaces (APIs); provision of technical interfaces (APIs) for connecting third-party applications for user-related output of information based on advice and recommendations; software for the encrypted and secure processing and transmission of medical data; provision of data protection-compliant software architectures; access control and authentication services; quality control.ACTIVE—
044Medical services; Health care services; digital medical services; medical support and consulting services; data consultation services relating to medical information; medical information and consulting services provided via general messenger apps; digital medical consulting using artificial intelligence software; therapy-accompanying care; providing medical information and patient support related to drug delivery therapies; providing healthcare advisory services via automated digital communication platforms; patient engagement services to support adherence to prescribed medical treatments; health monitoring services; health monitoring services relating to patient compliance with prescribed drug treatments; automated analysis of user and sensor data for medical purposes; data analysis for medical purposes using artificial intelligence software; health risk assessment.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 12, 2026RFNTREFUSAL PROCESSED BY IB—
Oct 27, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 22, 2026RFRRREFUSAL PROCESSED BY MPU—
Oct 1, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 16, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 15, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2026DOCKASSIGNED TO EXAMINER—
Aug 14, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 14, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 13, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance